Rentokil Initial
Stock Forecast, Prediction & Price Target
Rentokil Initial Financial Estimates
Rentokil Initial Revenue Estimates
Rentokil Initial EBITDA Estimates
Rentokil Initial Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $2.95B N/A | $3.71B 25.73% | $5.37B 44.72% | Avg: $5.78B Low: $5.70B High: $5.84B avg. 7.62% | Avg: $6.08B Low: $6.00B High: $6.15B avg. 5.16% | Avg: $8.50B Low: $8.39B High: $8.60B avg. 39.79% | |
Net Income
% change YoY
| $263M N/A | $232M -11.78% | $381M 64.22% | Avg: $515.90M Low: $439.69M High: $578.68M avg. 35.40% | Avg: $592.91M Low: $508.28M High: $679.76M avg. 14.92% | Avg: $4.28B Low: $4.21B High: $4.35B avg. 623.48% | |
EBITDA
% change YoY
| $692.7M N/A | $884M 27.61% | $1.15B 30.88% | Avg: $1.34B Low: $1.33B High: $1.36B avg. 16.64% | Avg: $1.41B Low: $1.40B High: $1.43B avg. 5.16% | Avg: $1.98B Low: $1.95B High: $2.00B avg. 39.79% | |
EPS
% change YoY
| $0.14 N/A | $0.12 -14.28% | $0.15 25% | Avg: $0.2 Low: $0.17 High: $0.23 avg. 35.57% | Avg: $0.23 Low: $0.2 High: $0.27 avg. 14.66% | Avg: $1.7 Low: $1.67 High: $1.72 avg. 627.98% | |
Operating Expenses
% change YoY
| $348.6M N/A | $479M 37.40% | $3.82B 698.12% | Avg: $728.54M Low: $718.57M High: $735.52M avg. -80.94% | Avg: $766.17M Low: $755.98M High: $775.61M avg. 5.16% | Avg: $1.07B Low: $1.05B High: $1.08B avg. 39.79% | |
FAQ
What is Rentokil Initial stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 224.60% in 2025-2027.
We have gathered data from 5 analysts. Their low estimate is 439.69M, average is 515.90M and high is 578.68M.
What is Rentokil Initial stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 17.52% in 2025-2027.
We have gathered data from 7 analysts. Their low revenue estimate is $5.70B, average is $5.78B and high is $5.84B.
What is Rentokil Initial stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 226.07% in 2025-2027.
We have gathered data from 5 analysts. Their low earnings per share estimate is $0.17, average is $0.2 and high is $0.22.
What is the best performing analyst?
In the last twelve months analysts have been covering Rentokil Initial stock. The most successful analyst is Ian Zaffino.